Search research articles
Contact Us
Filters
Showing results (1-10 of 123) with videos related to
Page
of 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?
David S Ettinger
The Oncologist
|
April 15, 2006
Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer
David S Ettinger
The Oncologist
|
June 18, 2002
Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer?
David S Ettinger
Clinical Lung Cancer
|
January 15, 2004
Pemetrexed (Alimta): a new antifolate for non-small-cell lung cancer
David S Ettinger
Oncology (Williston Park, N.Y.)
|
July 17, 2004
Overview and state of the art in the management of lung cancer
David S Ettinger
Seminars in Oncology
|
July 15, 2005
Non-small cell lung cancer treatment-related bone marrow toxicities
David S Ettinger
Oncology (Williston Park, N.Y.)
|
July 10, 2014
Lung cancer screening: has its time come?
David S Ettinger
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
Immunotherapy for Lung Cancer: Many Questions Yet to Be Answered
David S Ettinger
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Ten years of progress in non-small cell lung cancer
David S Ettinger
Seminars in Oncology
|
July 15, 2005
An overview of Eastern Cooperative Oncology Group stage III non-small cell lung cancer studies
David S Ettinger
Page
of 13
Search research articles
Search
Showing results (1-10 of 123) with videos related to
Sort By:
Page
of 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?
David S Ettinger
The Oncologist
|
April 15, 2006
Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer
David S Ettinger
The Oncologist
|
June 18, 2002
Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer?
David S Ettinger
Clinical Lung Cancer
|
January 15, 2004
Pemetrexed (Alimta): a new antifolate for non-small-cell lung cancer
David S Ettinger
Oncology (Williston Park, N.Y.)
|
July 17, 2004
Overview and state of the art in the management of lung cancer
David S Ettinger
Seminars in Oncology
|
July 15, 2005
Non-small cell lung cancer treatment-related bone marrow toxicities
David S Ettinger
Oncology (Williston Park, N.Y.)
|
July 10, 2014
Lung cancer screening: has its time come?
David S Ettinger
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
Immunotherapy for Lung Cancer: Many Questions Yet to Be Answered
David S Ettinger
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Ten years of progress in non-small cell lung cancer
David S Ettinger
Seminars in Oncology
|
July 15, 2005
An overview of Eastern Cooperative Oncology Group stage III non-small cell lung cancer studies
David S Ettinger
Page
of 13